Home LiteratureArticle Details
PMID: 16274482 Published · epublish English Journal Article Research Support, N.I.H., Extramural

Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant.

Retrovirology ·Vol. 2 ·2005-11-07 ·Pages 67

Zhang H, Hoffmann F, He J, He X, Kankasa C, Ruprecht R, West JT, Orti G, Wood C

Abstract

Given the high prevalence of mother to child infection, the development of a better understanding of African subtype C HIV-1 transmission and natural evolution is of significant importance. In this study, we genotypically and phenotypically characterized subtype C viruses isolated over a 67-month follow-up period from an in utero-infected Zambian infant. Changes in genotype and phenotype were correlated to alterations of the host humoral immune response. A comparison of baseline maternal and infant samples indicated that the infant sequences are monophyletic and contain a fraction of the diversity observed in the mother. This finding suggests that selective transmission occurred from mother to child. Peaks in infant HIV-1 Env genetic diversity and divergence were noted at 48 months, but were not correlated with changes in co-receptor usage or syncytia phenotype. Phylogenetic analyses revealed an accumulation of mutations over time, as well as the reappearance of ancestral lineages. In the infant C2-V4 region of Env, neither the median number of putative N-glycosylation sites or median sequence length showed consistent increases over time. The infant possessed neutralizing antibodies at birth, but these decreased in effectiveness or quantity with time. De novo humoral responses were detected in the child after 12 months, and corresponded with an increase in Env diversity. Our study demonstrates a correlation between HIV-1 Env evolution and the humoral immune response. There was an increase in genetic diversification in the infant viral sequences after 12 months, which coincided with increases in neutralizing antibody titers. In addition, episodes of viral growth and successive immune reactions in the first 5-6 years were observed in this slow progressor infant with delayed onset of AIDS. Whether this pattern is typical of slow progressing subtype C HIV-1 infected infant needs to be further substantiated.

MeSH Terms
Acquired Immunodeficiency Syndrome/immunology,transmission Adult Child, Preschool Disease Progression Evolution, Molecular Genes, env HIV Antibodies/blood HIV-1/classification,genetics Humans Infant Infectious Disease Transmission, Vertical Neutralization Tests Receptors, CCR5/physiology Virus Replication
Chemicals
HIV Antibodies Receptors, CCR5
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Zhang Hong
Nebraska Center for Virology, University of Nebraska, Lincoln, NE, USA. hongz@unlserve.unl.edu
Hoffmann Federico
He Jun
He Xiang
Kankasa Chipepo
Ruprecht Ruth
West John T
Orti Guillermo
Wood Charles
References (64)
64 references, click to expand
  1. Rapid evolution of the neutralizing antibody response to HIV type 1 infection.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4144-9 PMID: 12644702
  2. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.
    Science. 1992 Feb 28;255(5048):1134-7 PMID: 1546316
  3. MrBayes 3: Bayesian phylogenetic inference under mixed models.
    Bioinformatics. 2003 Aug 12;19(12):1572-4 PMID: 12912839
  4. DnaSP, DNA polymorphism analyses by the coalescent and other methods.
    Bioinformatics. 2003 Dec 12;19(18):2496-7 PMID: 14668244
  5. Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.
    J Virol. 2004 Jan;78(1):524-30 PMID: 14671134
  6. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.
    J Virol. 2004 Mar;78(6):2841-52 PMID: 14990703
  7. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.
    Science. 2004 Mar 26;303(5666):2019-22 PMID: 15044802
  8. Disease progression in heterosexual patients infected with closely related subtype B strains of HIV type 1 with differing coreceptor usage properties.
    AIDS Res Hum Retroviruses. 2004 Apr;20(4):365-71 PMID: 15157355
  9. TREEFINDER: a powerful graphical analysis environment for molecular phylogenetics.
    BMC Evol Biol. 2004 Jun 28;4:18 PMID: 15222900
  10. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group.
    N Engl J Med. 1989 Jun 22;320(25):1643-8 PMID: 2657430
  11. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms.
    Am J Dis Child. 1990 Nov;144(11):1210-5 PMID: 1978551
  12. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
    Science. 1991 Jul 5;253(5015):71-4 PMID: 1905842
  13. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
    J Virol. 1991 Dec;65(12):6931-41 PMID: 1658383
  14. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity.
    J Virol. 1992 Feb;66(2):757-65 PMID: 1731110
  15. Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies.
    J Acquir Immune Defic Syndr. 1992;5(3):303-7 PMID: 1740756
  16. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.
    J Virol. 1992 May;66(5):3183-7 PMID: 1560543
  17. Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies.
    J Clin Invest. 1995 Feb;95(2):732-7 PMID: 7860754
  18. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group.
    JAMA. 1996 Feb 28;275(8):606-10 PMID: 8594241
  19. Population dynamics of immune responses to persistent viruses.
    Science. 1996 Apr 5;272(5258):74-9 PMID: 8600540
  20. Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses.
    J Virol. 1996 Jun;70(6):3589-98 PMID: 8648693
  21. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection.
    Nat Med. 1996 Nov;2(11):1244-7 PMID: 8898753
  22. Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1.
    J Infect Dis. 1997 Jan;175(1):231-2 PMID: 8985228
  23. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease.
    J Virol. 1997 Jan;71(1):663-77 PMID: 8985398
  24. Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.
    J Exp Med. 1997 Feb 17;185(4):621-8 PMID: 9034141
  25. The puzzle of HIV-1 subtypes in Africa.
    AIDS. 1997 May;11(6):705-12 PMID: 9143601
  26. Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease.
    J Virol. 1997 Jun;71(6):4694-706 PMID: 9151863
  27. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection.
    J Virol. 1999 Dec;73(12):10489-502 PMID: 10559367
  28. The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity.
    J Virol. 2000 Feb;74(3):1149-57 PMID: 10627525
  29. Immunopathological factors for vertical transmission of HIV-1.
    Pathobiology. 2000 Mar-Apr;68(2):53-67 PMID: 10878502
  30. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.
    J Infect Dis. 2001 Jan 15;183(2):206-212 PMID: 11120927
  31. Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents.
    AIDS Res Hum Retroviruses. 2001 Jan 20;17(2):161-8 PMID: 11177395
  32. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum.
    J Virol. 2001 Mar;75(5):2194-203 PMID: 11160723
  33. Using HIV-1 sequence variability to explore virus biology.
    Virus Res. 2001 Aug;76(2):137-60 PMID: 11410314
  34. Evolutionary and immunological implications of contemporary HIV-1 variation.
    Br Med Bull. 2001;58:19-42 PMID: 11714622
  35. Vertical transmission of Kaposi's sarcoma-associated herpesvirus.
    Int J Cancer. 2001 Dec 1;94(5):749-52 PMID: 11745472
  36. Virologic risk factors for vertical transmission of HIV type 1 in Puerto Rico.
    AIDS Res Hum Retroviruses. 2002 Apr 10;18(6):447-60 PMID: 11958688
  37. Pediatric HIV-1 infection: advances and remaining challenges.
    AIDS Rev. 2002 Jan-Mar;4(1):21-6 PMID: 11998780
  38. Phylogenetic and phenotypic analysis of HIV type 1 env gp120 in cases of subtype C mother-to-child transmission.
    AIDS Res Hum Retroviruses. 2002 Dec 10;18(18):1415-23 PMID: 12512513
  39. Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A.
    J Virol. 2003 Mar;77(5):3050-7 PMID: 12584330
  40. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.
    J Virol. 2003 Apr;77(7):4449-56 PMID: 12634405
  41. Antibody neutralization and escape by HIV-1.
    Nature. 2003 Mar 20;422(6929):307-12 PMID: 12646921
  42. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.
    Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1721-5 PMID: 8446584
  43. V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability.
    J Virol. 1993 Sep;67(9):5623-34 PMID: 8350415
  44. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability.
    J Virol. 1993 Sep;67(9):5635-9 PMID: 8350416
  45. Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission.
    J Clin Invest. 1994 Jan;93(1):380-90 PMID: 8282808
  46. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.
    J Infect Dis. 1994 May;169(5):968-74 PMID: 7909549
  47. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission.
    J Virol. 1995 Feb;69(2):1001-12 PMID: 7815476
  48. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.
    J Virol. 1997 Oct;71(10):7498-508 PMID: 9311829
  49. PAML: a program package for phylogenetic analysis by maximum likelihood.
    Comput Appl Biosci. 1997 Oct;13(5):555-6 PMID: 9367129
  50. Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants.
    AIDS. 1997 Nov 15;11(14):1709-17 PMID: 9386805
  51. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
    Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 PMID: 9396791
  52. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene.
    Genetics. 1998 Mar;148(3):929-36 PMID: 9539414
  53. Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1.
    J Virol. 1998 Nov;72(11):8493-501 PMID: 9765386
  54. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.
    Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12568-73 PMID: 9770526
  55. MODELTEST: testing the model of DNA substitution.
    Bioinformatics. 1998;14(9):817-8 PMID: 9918953
  56. Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.
    J Infect Dis. 1999 May;179(5):1264-7 PMID: 10191234
  57. State of the HIV pandemic.
    J Hum Virol. 1998 Nov-Dec;1(7):427-9 PMID: 10195263
  58. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
    N Engl J Med. 1999 Aug 5;341(6):394-402 PMID: 10432324
  59. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.
    AIDS. 1999 Jul 30;13(11):1305-11 PMID: 10449282
  60. HIV-1 infection in children: a clinical and immunologic overview.
    Curr HIV Res. 2005 Jan;3(1):31-41 PMID: 15638721
  61. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.
    Bioinformatics. 2005 May 15;21(10):2531-3 PMID: 15713735
  62. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression.
    J Virol. 2005 Jul;79(14):9006-18 PMID: 15994794
  63. Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.
    J Virol. 2005 Jul;79(14):9026-37 PMID: 15994796
  64. High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment.
    J Virol. 2003 Jul;77(13):7682-8 PMID: 12805470
Article Info
Journal
Retrovirology
Abbr.
Retrovirology
ISSN
1742-4690
Published
2005-11-07
Epub
2005-00-07
Pages
67
Language
English
Region
England
NLM ID
101216893
PMCID
PMC1308862
Subset
IM
Grants
NICHD NIH HHS · R01 HD039620 · United States
FIC NIH HHS · TW01429 · United States
NIAID NIH HHS · R01 AI034266 · United States
FIC NIH HHS · D43 TW001429 · United States
NICHD NIH HHS · HD39620 · United States
NIAID NIH HHS · P01 AI048240 · United States
NIAID NIH HHS · P01 AI34266 · United States
NCRR NIH HHS · RR15635 · United States
NIAID NIH HHS · P01 AI 48240 · United States
NCI NIH HHS · CA76958 · United States
NCRR NIH HHS · P20 RR015635 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com